Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $64.59 billion. The enterprise value is $75.93 billion.
| Market Cap | 64.59B |
| Enterprise Value | 75.93B |
Important Dates
The last earnings date was Wednesday, October 28, 2026, before market open.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.45 billion shares outstanding. The number of shares has decreased by -0.91% in one year.
| Current Share Class | 1.45B |
| Shares Outstanding | 1.45B |
| Shares Change (YoY) | -0.91% |
| Shares Change (QoQ) | -1.55% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 92.79% |
| Float | 1.44B |
Valuation Ratios
The trailing PE ratio is 18.82 and the forward PE ratio is 14.47. BSX's PEG ratio is 1.42.
| PE Ratio | 18.82 |
| Forward PE | 14.47 |
| PS Ratio | 3.10 |
| Forward PS | 3.17 |
| PB Ratio | 2.55 |
| P/TBV Ratio | 1,923.96 |
| P/FCF Ratio | 19.64 |
| P/OCF Ratio | 15.45 |
| PEG Ratio | 1.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.78, with an EV/FCF ratio of 23.04.
| EV / Earnings | 21.92 |
| EV / Sales | 3.64 |
| EV / EBITDA | 13.78 |
| EV / EBIT | 18.55 |
| EV / FCF | 23.04 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.36 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 2.15 |
| Debt / FCF | 3.59 |
| Interest Coverage | 11.03 |
Financial Efficiency
Return on equity (ROE) is 14.12% and return on invested capital (ROIC) is 10.62%.
| Return on Equity (ROE) | 14.12% |
| Return on Assets (ROA) | 5.87% |
| Return on Invested Capital (ROIC) | 10.62% |
| Return on Capital Employed (ROCE) | 10.48% |
| Weighted Average Cost of Capital (WACC) | 6.78% |
| Revenue Per Employee | $357,119 |
| Profits Per Employee | $59,356 |
| Employee Count | 59,000 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, BSX has paid $162.00 million in taxes.
| Income Tax | 162.00M |
| Effective Tax Rate | 4.43% |
Stock Price Statistics
The stock price has decreased by -56.47% in the last 52 weeks. The beta is 0.59, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -56.47% |
| 50-Day Moving Average | 44.07 |
| 200-Day Moving Average | 54.39 |
| Relative Strength Index (RSI) | 51.44 |
| Average Volume (20 Days) | 19,895,143 |
Short Selling Information
The latest short interest is 40.71 million, so 2.81% of the outstanding shares have been sold short.
| Short Interest | 40.71M |
| Short Previous Month | 46.50M |
| Short % of Shares Out | 2.81% |
| Short % of Float | 2.82% |
| Short Ratio (days to cover) | 2.17 |
Income Statement
In the last 12 months, BSX had revenue of $21.07 billion and earned $3.50 billion in profits. Earnings per share was $2.37.
| Revenue | 21.07B |
| Gross Profit | 14.32B |
| Operating Income | 4.14B |
| Pretax Income | 3.66B |
| Net Income | 3.50B |
| EBITDA | 5.57B |
| EBIT | 4.14B |
| Earnings Per Share (EPS) | $2.37 |
Balance Sheet
The company has $609.00 million in cash and $11.95 billion in debt, with a net cash position of -$11.34 billion or -$7.83 per share.
| Cash & Cash Equivalents | 609.00M |
| Total Debt | 11.95B |
| Net Cash | -11.34B |
| Net Cash Per Share | -$7.83 |
| Equity (Book Value) | 25.87B |
| Book Value Per Share | 17.68 |
| Working Capital | 2.18B |
Cash Flow
In the last 12 months, operating cash flow was $4.23 billion and capital expenditures -$903.00 million, giving a free cash flow of $3.33 billion.
| Operating Cash Flow | 4.23B |
| Capital Expenditures | -903.00M |
| Depreciation & Amortization | 1.43B |
| Net Borrowing | 522.00M |
| Free Cash Flow | 3.33B |
| FCF Per Share | $2.30 |
Margins
Gross margin is 67.98%, with operating and profit margins of 19.64% and 16.62%.
| Gross Margin | 67.98% |
| Operating Margin | 19.64% |
| Pretax Margin | 17.35% |
| Profit Margin | 16.62% |
| EBITDA Margin | 26.44% |
| EBIT Margin | 19.64% |
| FCF Margin | 15.81% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.91% |
| Shareholder Yield | 0.91% |
| Earnings Yield | 5.31% |
| FCF Yield | 5.09% |
Analyst Forecast
The average price target for BSX is $49.60, which is 11.31% higher than the current price. The consensus rating is "Buy".
| Price Target | $49.60 |
| Price Target Difference | 11.31% |
| Analyst Consensus | Buy |
| Analyst Count | 31 |
| Revenue Growth Forecast (3Y) | 3.07% |
| EPS Growth Forecast (3Y) | 3.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 4.24 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.24 |
| Piotroski F-Score | 5 |